Health
111 to Collaborate with MSH to Build Internet Pharmaceutical and Healthcare Service Closed-loop System
SHANGHAI, May 24, 2019 /PRNewswire/ -- Following 111, Inc.'s (NASDAQ: YI) ("111" or the "Company") strategic partnership with Manulife-Sinochem last year, the Company has reached another milestone. OnMay 24, 111 and MSH, a world leader in the design and management of international healthcare solu...
2019-05-24 22:45
8419
CTONG-OrigiMed New Clinical Trial Sharing Platform Launched during the 3rd OrigiMed Summit for Cancer Discovery
SHANGHAI, May 24, 2019 /PRNewswire/ -- With fast advances in the medical industry, onMay 11, 2019, the third OrigiMed Summit for Cancer Discovery: Immunotherapy and Targeted Therapy was successfully held inGuangzhou. The summit was sponsored by the Chinese Thoracic Oncology Group (CTONG) and the ...
2019-05-24 19:00
4484
B dot Medical Developing Ultra-compact Proton Cancer Therapy System That Can Replace X-ray Cancer Therapy System
TOKYO, May 24, 2019 /PRNewswire/ -- B dot Medical Inc. announced on May 24 that the company has initiated the development of an ultra-compact proton cancer therapy system that can replace the commonly used x-ray cancer therapy system (LINAC). More than 180,000 patients have been treated in proto...
2019-05-24 14:00
2525
Ovid Therapeutics to Present at the 12th International Epilepsy Colloquium
First scientific presentation of OV-935 (TAK-935) safety and tolerability data in developmental and epileptic encephalopathies from the Phase1b/2a clinical trial Study met primary safety and tolerability endpoints and showed initial evidence of potential efficacy in seizure reduction Data encou...
2019-05-24 05:04
7440
APRINOIA Therapeutics Awarded Grant from The Michael J. Fox Foundation for Parkinson's Research
TAIPEI, , May 23, 2019 /PRNewswire/ -- APRINOIA Therapeutics, a clinical-stage biotechnology company with a pipeline of therapeutics and imaging diagnostics for neurodegenerative diseases, announces today that it has been awarded a research grant from The Michael J. Fox Foundation for Parkinson'...
2019-05-23 20:00
2942
MGI introduces total solution for single cell RNA sequencing using MGISEQ-2000 sequencing platform compatible with 10x Genomics
TOKYO, May 23, 2019 /PRNewswire/ -- MGI
2019-05-23 19:02
2917
Phebra establishes new subsidiary in Canada and announces marketing approval for its IV Arsenic Trioxide Solution
SYDNEY, May 23, 2019 /PRNewswire/ -- Australian pharmaceutical firm Phebra (the 'Company') has continued its international business expansion with the opening of its subsidiary inMontreal, Canada. The new entity, Phebra Canada, will be headed byTony Romagnino, Vice President of Phebra's current N...
2019-05-23 17:00
1786
Tencent Miying Launches AI-supported Auxiliary Diagnostic System
KUNMING, China, May 22, 2019 /PRNewswire/ -- Tencent today announces the launch of an AI-supported auxiliary diagnostic system for conducting digital colposcopy at the Global Digital Ecosystem Summit being held inKunming, China. This latest technology can rapidly identify the cervical transforma...
2019-05-23 04:47
7538
China SXT Pharmaceuticals, Inc. Being Admitted to Hi-tech Zone of Huangshan City in Anhui Province
TAIZHOU, China, May 22, 2019 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacture, marketing and sales of Traditional Chinese Medicine Pieces ("TCMPs"), announced today the laun...
2019-05-22 23:20
6988
Vitaeris Announces Multiple Scientific Presentations Involving Clazakizumab at the 2019 American Transplant Congress
- Anti-Interleukin 6 Monoclonal Antibody for Antibody-Mediated Kidney Transplant Rejection - 8 Oral & Poster Presentations VANCOUVER, British Columbia, May 22, 2019 /PRNewswire/ -- Vitaeris Inc. (Vitaeris) today announced that eight abstracts involving or related to clazakizumab, Vitaeris' pro...
2019-05-22 20:30
1788
Scientists Identify New Therapeutic Target for Fatty Liver Disease
* Preclinical study highlights a novel therapy for the treatment of fatty liver disease, which affects up to 25% of the global population * Inhibiting interleukin 11 (IL11) signalling addresses multiple aspects of non-alcoholic steatohepatitis (NASH), including hepatic inflammation and fibros...
2019-05-22 18:24
1960
FDA Approves SORILUX(R) for Adolescent Plaque Psoriasis
ADELAIDE, Australia, May 22, 2019 /PRNewswire/ -- Mayne Pharma Group Limited (ASX: MYX) is pleased to announce that the US Food and Drug Administration (FDA) has approved SORILUX® (calcipotriene) Foam, 0.005% in adolescents. SORILUX is now approved for treating plaque psoriasis of the scalp and b...
2019-05-22 18:00
6568
GPHL's first overseas scholarship established in partnership with University of Auckland
AUCKLAND, New Zealand, May 21, 2019 /PRNewswire/ -- The recent Conference on Dialogue of Asian Civilizations has not just helped various civilizations flourish through dialogues and exchanges, but also drivenChina's national brands to integrate into the world with stronger cultural confidence. On...
2019-05-21 16:58
1961
Saluda Medical Announces New 3-Month, 12-Month and 18-Month Data Featuring Evoke® ECAP-Controlled, Closed-Loop SCS System to be Presented at 14th INS World Congress
11 Presentations – Including 4 Plenary Presentations – to Feature the Evoke System ARTARMON, Australia, May 20, 2019 /PRNewswire/ -- Saluda Medical Pty Limited ("Saluda Medical") today announced that new data from multiple studies evaluating the company's Evoke® ECAP-Controlled, Closed-Loop Spin...
2019-05-20 16:00
1739
Bridge Biotherapeutics Announces Data Presentation from First-in-Human Study of BBT-877 for Idiopathic Pulmonary Fibrosis
SEONGNAM, South Korea and DALLAS, May 20, 2019 /PRNewswire/ -- Bridge Biotherapeutics Inc., a clinical-stage biotech company developing novel therapeutics for areas with high unmet medical needs, announced that the company presented interim data from a Phase I clinical study on BBT-877, a drug c...
2019-05-20 08:38
1812
ChemPartner and Berkeley Lights Take Next Step in B Cell Antibody Discovery Collaboration
SHANGHAI and SOUTH SAN FRANCISCO, Calif., May 16, 2019 /PRNewswire/ -- Shanghai
ChemPartner
2019-05-16 23:00
1775
Hebron Technology Co., Ltd. Reports Fiscal Year 2018 Financial Results
WENZHOU, China, May 15, 2019 /PRNewswire/ -- Hebron Technology Co., Ltd. (" Hebron" or the "Company") (Nasdaq: HEBT), a developer, manufacturer and installer of valves and pipe fittings for use in the pharmaceutical, biological, food and beverage, and other clean industries, today announced its f...
2019-05-16 05:00
11012
NeuClone to Initiate Phase I Clinical Trial of Stelara (Ustekinumab) Biosimilar, the Second Biosimilar from the 10-product Portfolio with Serum Institute
SYDNEY, May 15, 2019 /PRNewswire/ -- NeuClone Pharmaceuticals Ltd. (NeuClone), a clinical-stage biopharmaceutical company exclusively focused on developing high-quality biosimilar products, today announced it will initiate the Phase I clinical trial of its Stelara® (ustekinumab) biosimilar in t...
2019-05-15 20:13
1896
China Pharma Holdings, Inc. Reports First Quarter 2019 Financial Results
HAIKOU, China, May 15, 2019 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced financial results for the quarter ...
2019-05-15 18:00
8358
Hong Kong Science Park Leads Start-Up Delegation to North America's Fastest Growing Technology Conference in Toronto
HONG KONG, May 15, 2019 /PRNewswire/ -- Hong Kong Science and Technology Parks Corporation ("HKSTP") today announced that it is leading a delegation of 14 start-ups to Collision, one ofNorth America's leading technology conference, to be held inToronto, Canada from May 20 - 23, 2019. Leveraging o...
2019-05-15 16:02
2164
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 291 media titles]
2024-04-30 10:11
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
[Picked up by 274 media titles]
2024-04-24 17:09
Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39
Introducing Wacom Movink: The first OLED pen display, and the thinnest and lightest Wacom pen display ever
[Picked up by 268 media titles]
2024-04-24 13:00
Most Read
Automation Anywhere Appoints Tim McDonough as Chief Marketing Officer to Drive Global Awareness and Growth for the Leader in AI-Powered Automation
2024-04-24 03:57
7889
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
2024-04-24 17:09
6989
Introducing Wacom Movink: The first OLED pen display, and the thinnest and lightest Wacom pen display ever
2024-04-24 13:00
4283
Scienjoy Holding Corporation Reports Fiscal Year 2023 Financial Results
2024-04-27 04:30
2919